On July 27, 2021, Spectral Medical Inc. completed a bought deal financing of 23,530,000 units at a price of $0.425 per unit for aggregate gross proceeds of $10 million. Each unit consisted of one common share and one-half of one common share purchase warrant of Spectral, with each whole warrant entitling the holder thereof to acquire one common share at a price of $0.50 for a period of three years from the closing date.
The offering was conducted by Paradigm Capital Inc., as sole Canadian underwriter and bookrunner, and A.G.P./Alliance Global Partners, as the exclusive U.S. placement agent.
Cassels acted for Paradigm.